Veracyte (VCYT) Tops Q2 EPS by 12c

Veracyte (NASDAQ: VCYT) reported Q2 EPS of ($0.13), $0.12 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $55.1 million versus the consensus estimate of $48.06 million.

GUIDANCE:

Veracyte sees FY2021 revenue of $200-208 million, versus the consensus of $197.9 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c